| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is experiencing significant advancements in drug development, particularly with successful trial results for its leukemia drug Jaypirca and the positive market response to its new GLP-1 pill. The company's acquisition of CrossBridge Bio highlights its commitment to enhancing innovative drug technologies, especially in the area of dual-payload antibody-drug conjugates. Furthermore, the effectiveness of Foundayo in weight reduction positions the company strongly within the obesity treatment market. However, challenges remain in the development of new weight-loss drugs indicating varying performance in innovative product development. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.4 is modestly bearish. The market sentiment at 1.1 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1.2, and the negative at -0.1 on 2026-04-17. The forces of and Stock Price Trend (-0.4) will drive down the price. The forces of Price Level Sentiment (0), Sector Price Trend (0.4), Option Sentiment (0.8), Sentiment towards Fundamentals (1.7), Market Risk Appetite (2), and Valuation Sentiment (2.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | 0%(0%) | 926.79 | 2.29% | 58 | 2.59% | -0.1% | -0.4 | 0.5 | 1.1% | 1.1 | Long | 55% | 1.7 | 4 |
| 2026-04-16 | 0%(0%) | 903.43 | 2.34% | 31 | -0.19% | -0.55% | -1.8 | -0.4 | 1.2% | 0.6 | Short | 65% | 1.1 | 5.5 |
| 2026-04-15 | 0%(0%) | 905.13 | 2.3% | 32 | -1.94% | -0.16% | -1.3 | -0.5 | 1.5% | 0.7 | Short | 55% | 1.8 | -5.5 |
| 2026-04-14 | 0%(0%) | 923.03 | 2.24% | 52 | -0.67% | 0.39% | -0.2 | -0.4 | 0.5% | 0.9 | Short | 55% | 1.9 | -1 |
| 2026-04-13 | 0%(0%) | 929.23 | 2.72% | 54 | -1.09% | 0.56% | 0.4 | -0.3 | 1.1% | 0.8 | Short | 55% | 2.1 | -1 |
| 2026-04-12 | 0%(0%) | 0.4 | -0.3 | 0.7 | 1.5 | -1 | ||||||||
| 2026-04-11 | 0%(0%) | 0.4 | -0.3 | 0.8 | 1.9 | 6 | ||||||||
| 2026-04-10 | 0%(0%) | 939.46 | 3.04% | 60 | -1.65% | 0.47% | 0.4 | 0 | 1% | 1 | Long | 55% | 2.3 | -5 |
| 2026-04-09 | 0%(0%) | 955.19 | 3.18% | 71 | 0.2% | 0.42% | 0.2 | 0 | 1% | 0.8 | Long | 55% | 3.3 | 6.3 |
| 2026-04-08 | 0%(0%) | 953.3 | 3.53% | 66 | 2.41% | 0.55% | 1 | 0 | 1% | 0.8 | Long | 55% | 2.9 | -1 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-04-17 17:02:27 The introduction of Eli Lilly's new weight-loss drug reflects the company's ongoing efforts in innovative product development within the pharmaceutical sector. |
| 2026-04-17 17:02:27 Eli Lilly's CEO mentioned that financial constraints could limit the reach of weight-loss drugs, affecting potential market size. |
| 2026-04-17 17:02:27 Recent activity by several investment firms acquiring shares in Eli Lilly indicates a bullish outlook on the company's growth potential. |
| 2026-04-17 17:02:27 Despite the initial slow uptake of its weight-loss drug, Eli Lilly's stock has shown resilience, indicating investor confidence. |
| 2026-04-17 17:02:27 Eli Lilly is facing competition in the obesity treatment market, particularly from Novo Nordisk, as its new weight-loss drug sees lower-than-expected uptake. |
| 2026-04-17 15:48:20 Referring to Lilly's long history amplifies the significance and potential impact of the recent changes. |
| 2026-04-17 15:48:20 The mention of a recent dip indicates concerns regarding the company's earnings and financial health. |
| 2026-04-17 15:48:20 The potential to invest in a company at a lower price may be viewed positively by analysts. |
| 2026-04-17 13:49:11 The article reflects on the competitive landscape between Eli Lilly and Novo Nordisk in the weight-loss drug market. |
| 2026-04-17 13:49:11 It highlights challenges in reaching potential users of weight-loss drugs due to systemic issues in healthcare delivery and financial barriers. |
| 2026-04-17 13:49:11 The article discusses the potential market for weight-loss drugs, indicating a strong demand and significant revenue projections. |
| 2026-04-17 09:34:48 The article discusses the strong market response to Lilly's new GLP-1 pill, evidenced by the high number of prescriptions in its initial week. |